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Cryopreservation protocols are increasingly required in regenerative medicine applications but must deliver
functional products at clinical scale and comply with Good Manufacturing Process (GMP). While GMP
cryopreservation is achievable on a small scale using a Stirling cryocooler-based controlled rate freezer (CRF)
(EF600), successful large-scale GMP cryopreservation is more challenging due to heat transfer issues and
control of ice nucleation, both complex events that impact success. We have developed a large-scale cryocooler-
based CRF (VIA Freeze) that can process larger volumes and have evaluated it using alginate-encapsulated liver
cell (HepG2) spheroids (ELS). It is anticipated that ELS will comprise the cellular component of a bioartificial
liver and will be required in volumes of*2 L for clinical use. Sample temperatures and Stirling cryocooler power
consumption was recorded throughout cooling runs for both small (500mL) and large (200mL) volume samples.
ELS recoveries were assessed using viability (FDA/PI staining with image analysis), cell number (nuclei count),
and function (protein secretion), along with cryoscanning electron microscopy and freeze substitution techniques
to identify possible injury mechanisms. Slow cooling profiles were successfully applied to samples in both the
EF600 and the VIA Freeze, and a number of cooling and warming profiles were evaluated. An optimized cooling
protocol with a nonlinear cooling profile from ice nucleation to - 60C was implemented in both the EF600 and
VIA Freeze. In the VIA Freeze the nucleation of ice is detected by the control software, allowing both noninvasive
detection of the nucleation event for quality control purposes and the potential to modify the cooling profile
following ice nucleation in an active manner. When processing 200mL of ELS in the VIA Freeze—viabilities at
93.4%– 7.4%, viable cell numbers at 14.3– 1.7 million nuclei/mL alginate, and protein secretion at 10.5– 1.7mg/
mL/24 h were obtained which, compared well with control ELS (viability - 98.1%– 0.9%; viable cell numbers
- 18.3– 1.0 million nuclei/mL alginate; and protein secretion - 18.7– 1.8mg/mL/24 h). Large volume GMP
cryopreservation of ELS is possible with good functional recovery using the VIA Freeze and may also be applied
to other regenerative medicine applications.
Introduction
One bottleneck in manufacturing and clinical deliveryof regenerative medicine is successful cryopreserva-
tion. The preservation of cells to current Good Manu-
facturing Process (cGMP) requires validated, reproducible,
and safe methods.1 However, cryopreservation provides
various challenges in this context. These include retention of
good functionality, sterility, and scale up: for example, es-
timates for a bioartificial liver indicate that cryopreservation
of 2 L of alginate-encapsulated cell spheroids (ELS) are
required.2
Cryopreservation in bags of large volumes ( > 100mL) of
adult stem cells3 and of mammalian tissue culture cells4–6
using conventional liquid nitrogen-based controlled rate
freezers (CRFs) is established. However, the use of liquid
nitrogen is problematic in a GMP environment; following
manufacture, liquid nitrogen contains very low levels of
contaminants, but during transport and storage it can be-
come contaminated by ice, inanimate debris, and viable
microorganisms7–9 that can transfer to the local envi-
ronment.7,10 It is possible to filter industrial quantities of
liquid nitrogen to appropriate standards and the UV sterili-
zation of liquid nitrogen has been proposed11; however,
1UCL Institute for Liver and Digestive Health–Liver Group, University College Medical School, London, United Kingdom.
2University Department of Surgery, University College Medical School, London, United Kingdom.
3Asymptote Ltd, St Johns Innovation Centre, Cambridge, United Kingdom.
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unless liquid nitrogen is filtered or sterilized by validated
methods it cannot be used in a clean room without compro-
mising air quality. An alternative strategy, avoiding the re-
quirement for nitrogen during cooling is the use of CRF based
on electrically powered Stirling cryocoolers, which operate
efficiently down to cryogenic temperatures. Equipment based
on Stirling cryocoolers has been successfully used for con-
trolled rate freezing of a range of cell types including human
embryonic stem cells and ELS12,13 but this equipment is
limited to processing to small volumes (< 50mL total).
In this study, we address the issues of scaling up small
volume cryopreservation methods and the development of
cryocooler-based equipment for the large volume GMP
compatible process. Initially, a set of feasibility experiments
was carried out in cryovials applying a range of cooling
profiles to investigate the effects of the physical conditions
and thermal histories anticipated during cryopreservation in
large volumes. We also investigated control of ice nucle-
ation during scale up, which is essential for high cell via-
bility in many cryopreservation protocols.13 We also
investigated final cell:cryoprotectant volume ratios, since it
is desirable to reduce the overall sample volume as this
determines heat transfer both during controlled slow cooling
and rapid warming in large volumes.3 Finally, the large-
scale Stirling cryocooler-based CRF (VIA Freeze) was used
with ELS as a model system for equipment development and
optimization.
Materials and Methods
Cell culture
HepG2 cells were obtained from the ECACC (Wiltshire,
United Kingdom) and maintained in modified MEM-alpha
medium (Gibco, Paisley, United Kingdom) supplemented
with 10% FBS (Hyclone, Loughborough, United Kingdom),
100 IU/mL penicillin, and 0.1mg/mL streptomycin. HepG2
cells were not used beyond passage 50.
The techniques of alginate encapsulation and culture to
achieve competent ELS have been described previously.
Alginate beads have an approximate diameter of 500mm.
HepG2 cell spheroids are not uniformly spherical but are
typically irregular shaped.2,14 For small volume experiments,
ELS were maintained in static culture for 7 days in six-well
plates in media supplemented with glucose to a final con-
centration of 22.5mM, with 10% FFP in place of FCS.2 For
large volume experiments, ELS were maintained in culture
for 11 days in a fluidized bed bioreactor. Fifty percent, 70%,
and 80% media changes were performed on days 6, 8, and 10
respectively.2 For all experiments, cell density within ELS
was *20· 106/mL alginate. The exact cell densities within
each set of experiments are given in Tables 1, 2, and 3 under
‘‘unfrozen control.’’ These cell densities represent the stan-
dard densities achieved following conditioning culture.
Cryopreservation
Cryoprotectants. ELS were cryopreserved in cryopro-
tectant (CPA) of 12% DMSO with 10% FFP15 in University
of Wisconsin solution with 500 IU/mL catalase and 1.7mM
Trolox as antioxidants15 – 1mg/mL crystalline cholesterol to
act as a nucleant.16 Unless stated otherwise, the ratio of
volumes of ELS to CPA in cryovials was 1:1 representing a
cell density of *10· 106/mL. In some experiments, once
alginate beads had been transferred into cryovials and al-
lowed to settle under gravity, the ratios of ELS to CPA were
modified by removing supernatant CPA, to achieve ratios of
1:2/3, 1:1/3, and 1:0 (i.e., removal of all supernatant CPA).
Controlled rate freezers. Feasibility experiments in
cryovials: For feasibility experiments in small volumes, an
EF600 (Grant Instruments, Cambridgeshire, United King-
dom) was used.17 Cryovials (375418; Nunc, Loughborough,
United Kingdom) (capacity 1.8mL) were loaded with
0.25mL ELS equilibrated with 0.25mL chilled (4C) CPA
prior to cooling.
Large volume experiments in cryobags: For large volume
experiments, a VIA Freeze (Asymptote Ltd, Cambridge,
United Kingdom) was used to cryopreserve ELS in cryobags
(Fig. 1). In this device, cooling of a horizontal sample plate
was achieved by two Stirling cryocoolers connected to a
metal plate, directly onto which the cryobags were placed
(cooling was achieved from one side of the bag only). The
dimensions of the sample plate are 250· 450mm. The plate
temperature and the voltage applied to the VIA Freeze were
monitored and logged.
Table 1. Comparison of ELS Recovery at 24 h After Thawing Following Cryopreservation
at Different ELS:CPA Ratios
ELS:CPA ratio
(cell density)
Viability
(%)
Viable cell
number (106
nuclei/mL alginate)
Total
function
(lg AFP/24 h)
Normalized
function (lg AFP/106
nuclei/24 h)
Unfrozen control ( - ) 98.0 – 0.5 24.9 – 2.1 17.9 – 0.8 23.2 – 1.7
1:1 (12.5 · 106/mL) 95.9 – 2.3 21.0 – 2.2 11.8 – 1.1*** 18.2 – 2.1*
1:2/3 (15 · 106/mL) 95.4 – 1.4*** 19.9 – 2.2* 11.6 – 2.6*** 18.5 – 3.9
1:1/3 (18.75 · 106/mL) 96.2 – 1.3 17.7 – 1.3**,# 11.5 – 1.4*** 20.8 – 2.0
1:0 (25 · 106/mL) 95.3 – 1.6* 16.7 – 1.8**,## 10.5 – 1.7***,* 20.2 – 3.7
ELS were cooled in cryovials using the EF600. The rate of cooling was 1C/min and cholesterol was used as ice nucleant in all samples.
Each cryovial contained 250mL of ELS but the volume of CPA was varied. Four different ratios of ELS:CPA were tested: 1:1 (i.e., 250mL
ELS, 250mL CPA); 1:2/3; 1:1/3; and 1:0 (e.g., 250mL ELS, 0 mL CPA). ELS recovery (viability, viable cell numbers, and function) 24 h
after thawing was compared to unfrozen control. These data demonstrated that reducing the volume of CPA within the cryovial did not
reduce ELS recovery. n = 5– SD. *p< 0.05, **p < 0.01, ***p < 0.005 cf. unfrozen control. #p < 0.05, ##p < 0.01 cf. ELS cryopreserved at an
ELS:CPA ratio of 1:1. *p < 0.05 cf. ELS cryopreserved at an ELS:CPA ratio of 1:1/3.
ELS, encapsulated cell spheroids; CPA, cryoprotectant.
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For all runs the VIA Freeze was cooled to + 4C and held
at this temperature while samples were prepared. ELS were
equilibrated with chilled (4C) CPA and loaded into Cryo-
MACS bags (200-074-404; Miltenyi Biotec Ltd, Glasgow,
United Kingdom). Excess CPA was removed by rolling the
cryobags so that only *10mL excess CPA remained (with
*190mL ELS).
Once loaded onto the VIA Freeze, the plate was held for a
further 15min to allow ELS and plate temperature equili-
bration before cooling. The cryobags was compressed by a
styrofoam lid to achieve a uniform thickness (*4mm).
Cooling rates. Outcome assessments of cooling in
cryovials for characterization and feasibility experiments:
Five cooling profiles were examined in cryovials with ELS
containing*20 · 106 cells/mL alginate in the EF600. Three
were programmed (Figs. 2A and 3) to characterize ELS
recovery using different profiles down to - 100C:
1. A previously studied multi-step slow cooling profile16,18
2. A linear rate of cooling of 1C/min with a 10-min hold
period at - 8C (just below the estimated temperature
of ice nucleation in samples with ice nucleants)
3. A linear rate of cooling of 1C/min
Two further profiles (described in detail elsewhere19) de-
signed to model cooling in cryobags were also tested in
cryovials using the EF600 (Fig. 2A) These cooling rates
applied an average cooling rate of 1C/min between - 8C
and - 100C, with specific but different nonlinear segments
in the high subzero temperature range18:
4. ‘‘Controlled concentration’’ profile
5. ‘‘Constant change in ice fraction with time’’ profile
To discern whether or not ice nucleators were necessary
during cryopreservation, ELS were cooled in cryovials with
either cholesterol (an efficient ice nucleator)16 or with no
nucleator.
Cooling profiles used for large volume cryopreserva-
tion. Three cooling profiles (shown in Fig. 3) were used in
the VIA Freeze and these were replicated in the same ex-
periments in cryovials in the EF600 to directly compare ELS
recovery in cryobags to with ELS recovery in cryovials. The
first was a linear cooling rate of 1C/min (identical to profile
3 in Fig. 2A). The second and third profiles used for large
volume cryopreservation produced an average rate of cooling
of - 1C/min between - 8C and - 60C but were both
nonlinear.
Table 2. Comparison of ELS Recovery at 24 h After Thawing Using Different Warming Rates
Thawing
method
Time taken
to thaw (min)
Viability
(%)
Viable cell number
(106 nuclei/mL
alginate)
Function
(lg AFP/24 h)
Unfrozen control – 99.5– 0.6 17.7 – 0.9 15.3 – 2.8
37C water 1.75 – 0.5 97.8– 0.5*** 14.4 – 1.2** 8.7 – 1.8*
20C water 2.42 – 0.5 93.2– 1.7*** # 14.1 – 0.9** 7.5 – 0.3**
20C air 12.92 – 0.2 92.7– 3.1***,# 9.3 – 1.0***,##,** 6.5 – 0.9**,#
4C air 24.5 – 4.7 90.9– 4.9***,# 8.3 – 1.4***,###,** 5.8 – 0.5**,#
ELS were cooled in cryovials using the EF600. The rate of cooling was 1C/min and cholesterol was used as ice nucleant in all samples.
Following cooling, the cryovials were warmed using four different methodologies: 37C water; 20C water; 20C air; and 4C water to obtain
a range of warming rates. The times taken to thaw the cryovials using these four methodologies is given in column 2 (n= 2, mean– range).
ELS recovery (viability, viable cell numbers, and function) 24 h after thawing was compared to unfrozen control. These data demonstrate that
ELS recovery is greatest when rapid warming rates are applied. n= 5–SD. *p< 0.05, **p< 0.01, ***p< 0.005 compared to unfrozen control.
#p< 0.05, ##p< 0.01, ###p< 0.005 compared to ELS thawed in 37C water. **p< 0.01 compared to ELS thawed in 20C water.
Table 3. Direct Comparison of ELS Recovery After Cryopreservation Using Three
Different Cooling Profiles in Cryovials or Cryobags
Viability (%)
Viable cell
number (106
nuclei/mL alginate)
Function
(lg AFP/mL/24 h)
Unfrozen control 98.1 – 0.9 18.3 – 1.0 18.7 – 1.8
Profile A (Fig. 3) Cryovial 82.8 – 9.8 10.6 – 0.5 11.7– 4.4
Cryobag 79.7 – 13.0 10.0 – 0.6** 13.2– 1.2^^^
Profile B (Fig. 3) Cryovial 93.4 – 7.4 14.3 – 1.7 10.5– 1.7
Cryobag 85.9 – 5.5 15.2 – 1.7 12.0– 0.9^
Profile C (Fig. 3) Cryovial 62.0 – 10.8 6.4 – 0.5 5.7 – 0.6
Cryobag 77.2 – 11.2 12.9 – 1.8***,* 10.2– 0.8***
ELS were cryopreserved in either cryovials (small volume) or cryobags (large volume) alongside each other. Three different cooling
profiles (shown in Fig. 3) were tested. Cholesterol was included as ice nucleant in each and the ELS: CPA ratio was 1:0. ELS recovery
(viability, viable cell numbers, and function) 24 h after thawing was compared to unfrozen control. These results indicate that ELS recovery
from cryovials and cryobags did not differ when profiles A and B were applied during cooling, suggesting successful scale up of the
cryopreservation protocol. n = 5 – SD. ***p< 0.005 compared to ELS cryopreserved in cryovials using the same cooling profile. *p < 0.05,
**p < 0.01 compared to ELS cryopreserved in cryobags using profile B. ^p < 0.05, ^^^p < 0.005 compared to ELS cryopreserved in
cryobags using profile C.
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Temperature measurements during cooling. T-type
thermocouples connected to a Picolog TC-08 data logging
device (PicoTechnology, St Neots, United Kingdom) were
used to measure the temperatures of samples within bags
and cryovials. When the ELS reached programmed end-
temperatures, they were transferred to the vapor phase of
liquid nitrogen for storage ( > 1 day).
Warming. Routinely, ELS in either cryovials or bags
were removed from storage and transferred to a 37C water
bath until the last ice crystal had melted. Samples were then
placed on ice, ELS allowed to settle under gravity, super-
natant CPA removed, and washed using equal volumes of
chilled culture medium. This was then removed and re-
placed with complete, prewarmed, culture medium.
To achieve different rates of rewarming in the feasibility
studies, cryovials were warmed in + 4C air, + 20C air, or
+ 20Cwater. The times taken to thaw (when the last ice crystal
melted) from nitrogen storage (- 150C) were recorded.
Ultrastructure of cryopreserved samples
Cryoscanning electron microscopy. Cryovials containing
ELS were cooled using a linear cooling rate of - 1C/min in
the EF600 and transferred to liquid nitrogen. Cryovials were
fractured under liquid nitrogen and the frozen plug removed
intact. The plug was fractured vertically down the mid plane
under liquid nitrogen and then loaded onto the preparation
stage of a FEI Philips XL30 FEGSEM (Quorum PPT 2000).
The stage was warmed from - 145C to - 95C over 6min
and the sample etched at - 95C for 60min before cooling to
- 145C. The sample was then coated with 10–15 nm gold
and loaded back onto the cryoscanning electron microscopy
(CryoSEM) stage for image recording.
Freeze substitution. Some samples were refractured to
make segments with a maximum dimension of 1mm and then
transferred under liquid nitrogen to automated freeze substi-
tution chambers (Reichert; Leica, Vienna, Austria). The
substitution medium contained 2% osmium tetroxide and 1%
uranyl acetate in methyl alcohol as contrast agents. Samples
were maintained at - 90C for 24h, warmed to - 70C at
3C/h, and then maintained at - 70C for 24h. Afterward
FIG. 1. The VIA freeze. The VIA Freeze and controller on
the bench top (A), and (B) with lid open showing sample
plate and cryovial holder for quality assurance samples (on
left-hand plate edge).
FIG. 2. Impact of cooling profiles used for feasibility
experiments on small volume cryopreservation of encapsu-
lated cell spheroids (ELS). Five different cooling profiles
(A) were used to cool ELS in 1.8mL cryovials to - 100C.
These profiles are fully described in the Methods section of
this article. The effect of differing ice nucleation tempera-
tures on ELS viability using these profiles in post-thaw
cultures was also investigated (B). Cells were cooled by a
‘‘multi-step cooling’’ method (C),16,18 linear 1C/min (,),
linear 1C/min with an isothermal hold at - 8C (:), a
controlled concentration profile (>), or a constant change in
ice fraction with time (-).19 These data demonstrate that
regardless of cooling profile utilized, ELS viability in post-
thaw cultures is strongly correlated with ice nucleation
temperature. When ice nucleation occurs at higher temper-
atures (i.e., when cholesterol is present and there is only
minimal supercooling), ELS viability in post-thaw cultures
is typically high; conversely, if ice nucleation spontaneously
occurs at lower temperatures, supercooling will result in
poor ELS viability in post-thaw cultures.
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they were warmed to room temperature at + 3C/h, rinsed in
methyl alcohol, and embedded in Spurr’s epoxy resin. Sec-
tions were cut at 0.5mm thickness with a Reichert Ultracut S
and stained with methylene blue for preliminary inspection
and orientation.
Cell viability and function following freezing
and thawing
For small volume experiments in cryovials in the EF600,
ELS were returned to static culture in six-well plates fol-
lowing cryopreservation. For large volume experiments in
the Via Freeze, ELS were returned to culture in a rotating
cell culture system,14 which mimics the cell culture condi-
tions of the large-scale fluidized bed bioreactor used to
culture ELS prior to cryopreservation.
The methods used to assess recovery at 24 h post-
warming are described elsewhere.16 (This particular time
point post-warming was chosen as this represents the time at
which ELS viability would be lowest, before they begin to
recover.16) Briefly, ELS were stained using fluorescein
diacetate and propidium iodide and viabilities were quanti-
fied using image analysis.16 Cell numbers were measured by
releasing spheroids from alginate using 16mM EDTA/
0.15M NaCl (pH 7.4) and nuclei count using the Nucleo-
counter system. Function was assessed by measuring total a-
1-fetoprotein release in the first 24 h post-warming using
ELISA.
Statistical analysis
Statistical analyses were performed by one-way ANOVA
using Excel software. Each experiment to assess ELS re-
covery (viability, viable cell numbers, and function) was
performed with five replicates and data are presented in
Tables 1, 2, and 3 as the mean of these replicates – standard
deviation.
Results
Feasibility studies in cryovials
Effect of cooling profile and ice nucleation temperature on
ELS recovery. For scale up of the small-volume (0.5mL)
cryopreservation protocols it was necessary to examine the
effects of a number of physical variables. Five different
cooling profiles were examined (shown in Fig. 2A). ELS
were processed, with or without cholesterol as an ice nu-
cleator.
The recovery of ELS viability in post-warming cultures
was dependent on the temperature of ice nucleation during
cooling (Fig. 2B). When ice nucleation occurred at tem-
peratures below - 12C (in the absence of cholesterol) the
recoveries were*40%. However, at ice nucleation induced
at temperatures > - 8C (in the presence of cholesterol),
viability was typically greater than 90% on thawing. Re-
covery of ELS was most variable following the multi-step
cooling protocol. These data suggest that providing efficient
ice nucleation occurs, a linear cooling rate of - 1C/min
could be used in the large volume freezer and that deviations
from linearity, within the range of the two nonlinear profiles
examined, would be tolerated.
Ultrastructure in the frozen state. CryoSEM of ELS in
samples in which ice had either been nucleated in a con-
trolled manner (using cholesterol, Fig. 4A, C, E) or al-
lowed to occur spontaneously (Fig. 4B, D, F) revealed
major differences in the structure of both ice and ELS.
Where spontaneous ice nucleation occurred, a uniform fine
ice crystal structure ( < 25 mm diameter) was evident, as
etched voids, across the sample (honeycomb structure,
Fig. 4D). The outlines of spherical alginate beads are
detectable (Fig. 4B, D), and were similar in size to the
unfrozen alginate beads (*500 mm diameter), but any
cellular structure was generally masked by the pattern of
ice formation. In those instances where cells were appar-
ent (Fig. 4F), ice voids were apparent between cells, but
intracellular ice was not evident. In samples with con-
trolled nucleation, alginate beads were indistinguishable
(Fig. 4A). ELS were freeze-concentrated into large ag-
gregates (Fig. 4C, E); the individual ELS appeared highly
shrunken. Ice crystal voids were adjacent to the cell
clusters, and the alginate and extracellular matrix itself
appeared to be dehydrated. At higher magnification (Fig.
4E) the outlines of shrunken cells were distinguishable
within ELS. Any cellular material appeared granular,
while freeze-concentrated alginate and CPA appeared
smooth by comparison.
Freeze substitution of ELS within the induced ice-
nucleated sample revealed shrunken cells with densely
packed cytoplasm in which it was difficult to differentiate
intracellular structures (Fig. 5A). At higher magnification,
some cell membrane-like material could be seen but it was
difficult to distinguish further. Many clear ‘‘shrinkage
spaces’’ were evident. Following spontaneous ice nucleation
cells did not appear so shrunken (Fig. 5B) and at higher
magnification (Fig. 5D) intracellular organelles, such as mi-
tochondria, were identifiable and there were few ‘‘shrinkage
spaces.’’ Intracellular ice was not apparent in any samples,
but following spontaneous nucleation intercellular ice had
formed within cell clumps.
FIG. 3. Cooling profiles used for direct comparison of
ELS recovery in small and large volumes. Three different
cooling profiles were used to cool ELS in 1.8mL cryovials
using the EF600 and in 200mL cryobags using the VIA
Freeze to - 100C in parallel. A simple linear rate (A) was
compared with nonlinear profiles (B, C). In large volumes,
heat transfer occurs more slowly as a result of the increased
mass. These nonlinear profiles were utilized as these are a
more accurate representation of cooling profiles that would
be experienced by ELS cooled in large volumes, where
heat transfer would be altered compared with ELS cooled
in small volumes. They were derived using mathematical
modeling.19
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Effect of reduced CPA volume on ELS recovery. ELS
viability following a linear rate of cooling with cholesterol
as ice nucleant was high with no trend toward reduced vi-
ability by decreasing the ratio of ELS to CPA, even at the
highest cell density (*30· 106/mL). In contrast, lower vi-
able cell numbers and total AFP secretion suggested that
decreasing the volume of CPA was detrimental. However,
normalized AFP secretion was unaffected by reducing the
ELS:CPA ratio (Table 1). These data suggest that CPA vol-
ume, after a sufficient equilibration period, may be reduced
during large-volume experiments with limited effects on ELS
recovery; this simplifies application of large-volume cooling.
FIG. 4. Cryoscanning electron microscopy
of fractured cryovials after cooling at a lin-
ear rate of 1C/min. Ultrastructure resulting
from controlled ice nucleation (A, C, E) is
compared to spontaneous ice nucleation (B,
D, F). In all samples the spaces originally
occupied by ice crystals are revealed as
voids following sublimation of ice. In fig-
ures (B, D) sectioned alginate beads that are
*500mm in diameter are outlined. In (C, E,
F), cell clusters (c), ice voids (i), and smooth
freeze concentrated alginate and cryopro-
tectant (CPA) (*) have been labeled. Scale
bars on (A, B) 1mm, on (C, D) 200 mm, and
on (E, F) 20 mm.
FIG. 5. Freeze substitution of fractured
cryovials after cooling at a linear rate of
1C/min. Ultrastructure resulting from con-
trolled ice nucleation (A, C) is compared
with spontaneous ice nucleation (B, D). In
spontaneously nucleated samples, the spaces
originally occupied by ice crystals are re-
vealed as voids following sublimation of ice,
and can be seen throughout the ELS struc-
ture. These ice voids are absent within
cholesterol-nucleated ELS, although there is
evidence of shrinkage spaces. At higher
magnification, it is difficult to distinguish
cell organelles in cholesterol-nucleated ELS
due to the extreme cell dehydration during
cooling. Conversely, organelles can be seen
in spontaneously nucleated ELS. Cellular
material (c), ice voids (i), cell membrane
(cm), extracellular matrix (ecm), mitochon-
dria (m) shrinkage spaces (s), and alginate
(*) have been labeled. Scale bars on (A, B)
2 mm and on (C, D) 500 nm.
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Effect of warming conditions on ELS recovery. Fo-
llowing linear cooling at - 1C/min the recovery of ELS in
cryovials was adversely affected by the time taken for
warming (Table 2). Maximum recoveries were observed
following rapid warming although the effect on viability
was minor, with viabilities > 90% for all thawed ELS at 24 h
post-warming.
However, both viable cell numbers and function were
more affected by slower warming. Viable cell numbers
decreased to 47%, 53%, 79%, and 82% cf. those of unfrozen
controls when thawed using 4C air ( p < 0.005), 20C air
( p < 0.005), 20C water ( p< 0.01), and 37C water
( p < 0.01) respectively. Similarly, AFP secretion decreased
to 37%, 43%, 49% and 57% cf. those of unfrozen controls
when thawed using 4C air ( p < 0.01), 20C air ( p < 0.01),
20C water ( p < 0.01) and 37C water ( p < 0.05) respec-
tively. These data suggest that rapid warming is crucial to
ELS recovery.
Direct comparison of ELS cryopreservation in small
volumes in cryovials with large volumes in cryobags
Measurement of cooling profiles using the VIA freeze.
Temperature profiles from three different locations in Cryo-
MACS bags containing cell-free alginate beads equilibrated
with CPA are presented in Figure 6A and B along with
process parameters of the VIA Freeze. Data are shown for a
programmed linear cooling rate from + 4C to - 100C.
The measured temperature of the sample plate closely
followed the set point (programme) temperature and was
mirrored in a uniform way within the bag until ice nucle-
ation occurred. Following ice nucleation in the presence of
cholesterol, at a plate temperature of - 7.9C and a tem-
perature in the fluid at the bottom of the bag of - 5.4C,
there was a minor warming of the sample plate. To maintain
the programmed cooling profile, a feedback loop increased
the electrical power to the VIA Freeze, which then stabilized
at a temperature within the range of ice nucleation. When
cooling had progressed to £ - 30C and below throughout
the sample, the required power input for the VIA Freeze
reduced again to that recorded preice nucleation. Tem-
perature measurements within the bag (Fig. 6) show under-
cooling of the region in contact with the cold plate (Fig. 6A,
dark gray line) while at the same time the rest of the sample
was above the melting point of - 4.5C (Fig. 6A, mid- and
light-gray lines). Ice nucleation occurred at the cold wall
and heat was extracted as the ice front developed, shown by
increased power consumption by the Stirling motors. In this
configuration only a small region within the sample in
contact with the cold wall was under cooled, and ice prop-
agated through the bulk of sample with no localized under-
cooling.
Comparison of ELS recovery following cooling in cryobags
using three different cooling profiles. There were no sta-
tistically significant differences in viabilities of ELS cryo-
preserved in cryobags using the three different cooling
profiles (Table 3) ( p> 0.05). However, there were signifi-
cant differences in viable cell numbers. ELS cryopreserved
using Profile B showed significantly improved viable cell
numbers in post-thaw culture when compared with ELS
cryopreserved using either profile A ( p < 0.01) and profile C
( p< 0.05). Furthermore, function of ELS cryopreserved in
cryobags using Profile A was significantly improved
( p< 0.005) cf. ELS cryopreserved using Profile C. Profile B
also resulted in significantly improved function cf. Profile C
( p< 0.05).
Comparison of ELS recovery following cooling in either
cryovials or cryobags. Samples were cooled using the
profiles described in Figure 3, either in bags on the VIA
Freeze or in cryovials on the EF600. The measured time for
warming a bag containing 200mL of alginate beads (cell
free) from storage to 0C in a 37C water bath was*2min
(c.f. 1.75min in cryovials, Table 2).
ELS recoveries were assessed 24h post-warming and
compared to an unfrozen control at equivalent time point.
Using Profiles A or B (Fig. 3), there were no statistically
significant differences in recovery (viability, viable cell
number, or function) when ELS were cryopreserved in either
cryovials or CryoMACS bags (Table 3). However, following
Profile C (Fig. 3), ELS recovered from CryoMACS bags
displayed greater viable cell numbers ( p< 0.005) and function
( p< 0.005) than ELS cryopreserved in cryovials (Table 3).
FIG. 6. Process parameters and measured temperatures
within a CryoMACS bag during linear cooling on the VIA
Freeze. (A) The entire cooling run over 1 h 45min. Set point
temperature (solid black line). Measured temperatures
within the cryobag containing 200mL ELS, at the bottom of
the bag (dark gray line), in the middle (mid gray line) near
to the top (light gray line). Power input (% of maximum
electrical power) supplied to the VIA Freeze (dashed black
line on right hand Y axis). (B) Detail around ice nucleation
in the bags; note expanded X and Y axes: set point tem-
perature (solid black line); measured sample plate temper-
ature (dotted line); power input (% of maximum electrical
power) supplied to the VIA Freeze (dashed line on right
hand Y axis). Note the plate temperature shows a small
inflection in response to the latent heat of ice formation.
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Discussion
We have previously described that ELS possess many
useful synthetic and detoxification functions that could be
utilized in the treatment of acute liver failure.2,14–17 Further,
we have previously described that it is possible to cryo-
preserve ELS using both conventional liquid nitrogen and
nitrogen-free CRFs.16,17 This work goes beyond this and a
cryopreservation protocol developed for small volumes
(0.5mL) was successfully scaled up to large volumes
(*200mL) in a liquid nitrogen-free CRF, and a number of
modifications to the small-scale processes were investigated.
The Via Freeze CRF allowed accurate control of the rate of
cooling to - 100C, and has potential in processing large
volumes of cells within clean room facilities, avoiding the
issues associated with the use of liquid nitrogen-based sys-
tems. End temperatures of around - 90C are sufficiently
close to the glass transition range for this type of CPA
mixture (typically around - 110C20) to allow safe transfer
below - 150C for storage, supported by the fact that the
EF600 technology performed equally well compared with a
conventional liquid nitrogen CRF in our previous study.17
Although in this study, samples were stored in the vapor
phase of liquid nitrogen, Stirling cryocoolers capable of
maintaining temperatures below - 150C exist and could be
used to avoid liquid nitrogen entirely during the cryopres-
ervation process.
More importantly, in the context of standard cryopreser-
vation protocols, the data generated during feedback power
monitoring of the VIA Freeze may be used to confirm that
ice nucleation has been successful as detectable power
output is upregulated to compensate for latent heat release
following ice nucleation. For example, for cells in bags, the
absence of any voltage spikes at temperatures below a plate
temperature of - 12C would indicate that ice nucleation
had been successful and that the sample viability should be
high on warming. However, if a power-input spike was
observed at lower plate temperatures, then controlled ice
nucleation did not take place and significant undercooling
had occurred, predictive of low survival and poor post-
warming function. This may be both a valuable tool for
future monitoring of cryopreservation protocols for quality
control purposes in general, and active control of specific
freezing processes allowing automatic cooling profile
modification following ice nucleation to achieve beneficial
nonlinear profiles.12,19
The multi-step protocol previously used with small vol-
umes16 was not essential; provided that efficient controlled
ice nucleation occurred, simplified linear cooling rates were
as effective (Table 3). The response of ELS to different ice
nucleation temperatures demonstrates that as the extent of
undercooling increases, viability post-cryopreservation de-
creases. CryoSEM and freeze substitution showed that
controlled ice nucleation ensures significant cell shrinkage
during cooling (Figs. 4 and 5). The intracellular ‘‘shrinkage
spaces’’ have been reported elsewhere18 and are probably
artefacts associated within efficient chemical fixation of the
dehydrated sample (Fig. 5). In ELS that experienced ex-
treme undercooling before ice nucleation occurred, there
was little cell shrinkage (Fig. 4B), intracellular ice was not
apparent, and the cells exhibited what might be classed as
more ‘‘normal’’ morphology. Cellular dehydration occurs in
response to the increased extracellular solute concentration
that arises during ice formation as solutes are excluded from
the ice lattice. During spontaneous ice nucleation, cells are
unable to dehydrate, as ice formation is too rapid to allow
dehydration within the short time frame. Conversely, during
controlled nucleation, ice formation is slower, which en-
ables cells to dehydrate. Following spontaneous ice nucle-
ation, intercellular ice formed (Figs. 4F and 5B). This was
not observed in samples in which controlled ice nucleation
occurred and may be a stress that results in cell injury.
While visually counterintuitive, our data showed that func-
tional recoveries were lower when the ELS were more
identifiable as structural entities (Fig. 4B vs. A), which
agrees with other studies.21,22 This may reflect the impor-
tance of extreme dehydration for successful recovery from
the cryopreservation process.
Stochastic ice nucleation during cooling modifies a
number of physical processes within the freeze-concentrated
matrix and any cells present will experience differing mi-
croenvironments. In particular, in samples with controlled
ice nucleation the calculated diffusion distance within the
freeze concentrated matrix is significantly larger than that
following spontaneous ice nucleation.13 Effects on cell de-
hydration of controlled and spontaneous ice nucleation have
previously been confirmed using Fourier transform infrared
spectroscopy of mammalian cell lines23,24 and horse sper-
matozoa25 and it has been shown that cell dehydration is
required to avoid lethal intracellular ice formation.
A second aim of this study was to reduce the amount of
‘‘excess’’ CPA volume processed. This is not trivial because,
especially at scale up, this largely aqueous mass significantly
contributes to the energy required to be removed during
controlled cooling, and impacts on the ability to control the
temperature profile throughout the entire sample. Similarly
during recovery, excess CPA will limit the rate of warming,
which is known to influence cell recovery. When ELS were
equilibrated with CPA they could be frozen with little excess
CPA and retain high viability and function. With ELS, the
cell densities, (even with no ‘‘excess’’ CPA) were not high
(*3· 107/mL). In past studies, single cell suspensions,
cryopreserved at high cell densities (equivalent to low CPA/
biomass volume ratios), underwent significant damage, the
so-called ‘‘cell packing’’ effect,26,27 but the cell densities
were much higher than used here.
As ELS are encapsulated within alginate, it may be ex-
pected that the alginate itself offers some protection to the
spheroids during cryopreservation. Polymers such as hy-
droxyl-ethyl starch can contribute toward cryoprotective
effects in other systems28 and this has been attributed to
increasing the viscosity, and modifying the water-ice-
transition.29 A similar argument has been proposed for al-
ginate.30 However, in the large majority of cases (including
our current work), cell-permeating CPAs are still required. It
was clear from freeze-fracture studies (Fig. 4) that ice
crystals grew throughout the alginate microspheres, al-
though the control of ice nucleation appeared to result in
larger ice crystals. Thus, any cryoprotection afforded by the
alginate may result from complex interactions between
polymer distribution and the biophysical events of a par-
ticular cryopreservation protocol.
Cell losses were observed when ELS of high densities
were cryopreserved in small volumes; this could have
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resulted from handling issues (such as adherence of beads
inside tubes or pipettes). However, this was not seen during
large-scale cryopreservation in bags.
In this initial study the identified optimal nonlinear profile
was similar to that previously employed with cell clusters of
human embryonic stem cells.31 In this profile (Fig. 3, Profile
B) there is an extended holding period in the temperature
zone following ice nucleation, which allows more time for
osmotic equilibrium to be established between the cells and
the external environment at high subzero temperatures. Ul-
trastructural studies (Figs. 4 and 5) demonstrated that sig-
nificant cellular dehydration was protective; thus, osmotic
equilibration of the cells with the partially frozen matrix
during the extended holding period is one important com-
ponent of this. However, when using another nonlinear
profile (Fig. 3, Profile C), which further extended the period
at high subzero temperatures after ice nucleation, a reduced
recovery on thawing was observed, suggesting possible
cytotoxic effects still occurring at high subzero tempera-
tures. These are likely to contain components of both pro-
gressive osmotic injury and CPA toxicity. Further studies
are needed to optimize, nonlinear profiles.
The data presented here demonstrate that it is possible to
develop cryopreservation protocols in small volume
(0.5mL) samples, which can be scaled up to much larger
volumes (200mL).
A further step in scaling up cryobanking for ELS may
require moving from a flexible bag (200mL ELS) format to
a rigid cylindrical cassette (2000mL ELS). At these large
volumes, with a concomitant reduction in the surface area to
volume ratio of the sample, modeling suggests that heat
transfer properties can significantly vary between different
locations within the bulk three-dimensional volume as ex-
ternal cooling is applied32 with potential negative impact on
successful cryopreservation. Both cooling and warming
profiles will be affected. However, in the cryobag (thin film)
format, heat transfer (and therefore cooling and warming
rates) will not be significantly compromised compared with
those achieved in cryovials, explaining why good results
were obtained in both conditions during our current studies.
In translating cell therapies forward to the clinic and
implementing essential cryobanking steps, there are several
important considerations to achieve compliance with cGMP
standards. These will include the selection of an optimized
cryopreservation media and CPA mixtures, type and di-
mensions of containers, use of a liquid nitrogen-free CRF
with appropriate methods for controlled ice nucleation, and
detection of the nucleation process. All of these have been
discussed in relation to the current study.
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